Related Experiment Video

Updated: Jun 6, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

85.8K

Reviewing the Impact of Maternal Opioid Use Disorder on Fetal Development and Long-Term Pediatric Health Outcomes

Manahil Asad1, Felicia T Bonner-Reid2, Fawaz Aldoohan3

  • 1Medicine and Surgery, Fauji Foundation Hospital-Foundation University Medical College (FUMC) Islamabad, Islamabad, PAK.

Cureus
|November 25, 2024
PubMed

Insights

Maternal opioid use disorder (OUD) during pregnancy impacts fetal development, leading to neonatal abstinence syndrome (NAS) and long-term issues. Treatment options like OMT exist but carry risks, necessitating further research and multidisciplinary care.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatology
  • Public Health
  • Neuroscience

Background:

  • Opioid use during pregnancy presents a significant public health challenge.
  • Maternal opioid use disorder (OUD) affects maternal and infant health outcomes.
  • Rising prevalence of opioid use among pregnant women necessitates understanding its consequences.

Purpose of the Study:

  • To review the consequences of OUD and maternal opioid use during pregnancy.
  • To focus on fetal and pediatric outcomes, including neonatal abstinence syndrome (NAS).
  • To explore available treatment options and their associated risks and benefits.

Main Methods:

  • Literature review focusing on studies concerning maternal opioid use and pregnancy.
  • Analysis of fetal and pediatric outcomes, including neonatal abstinence syndrome (NAS), birth weight, and long-term neurodevelopmental effects.
  • Examination of current treatment strategies, such as opioid maintenance therapy (OMT) with methadone and buprenorphine.

Main Results:

  • Opioid exposure in utero is linked to adverse neonatal outcomes like NAS, preterm birth, and low birth weight.
  • Fetal opioid exposure can disrupt brain development, affecting synaptic plasticity, oligodendrocyte differentiation, and myelination.
  • Opioid maintenance therapy (OMT) can improve prenatal care adherence but is associated with risks like NAS and smaller birth weights.

Conclusions:

  • Maternal OUD requires a multidisciplinary approach for effective management.
  • Further research is crucial to understand long-term developmental impacts on children exposed to opioids in utero.
  • Developing enhanced prevention and intervention strategies for maternal OUD is essential.

Keywords:
methadonenaltrexoneneonatal careopiod abusepregnancy

More Related Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes05:25

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

177
Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.0K

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
225
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
513
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
183
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
232
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K